Home/Filings/4/0001104659-22-108947
4//SEC Filing

Hopkins Mary J 4

Accession 0001104659-22-108947

CIK 0001428875other

Filed

Oct 13, 8:00 PM ET

Accepted

Oct 14, 7:05 PM ET

Size

23.9 KB

Accession

0001104659-22-108947

Insider Transaction Report

Form 4
Period: 2022-10-12
Hopkins Mary J
Vice Pres, Controller & CAO
Transactions
  • Disposition to Issuer

    Employee Stock Options

    2022-10-123,5970 total
    Exercise: $36.35Exp: 2028-03-04Common Stock (3,597 underlying)
  • Disposition to Issuer

    Employee Stock Options

    2022-10-12$1.22/sh3,010$3,6720 total
    Exercise: $37.07Exp: 2028-02-18Common Stock (3,010 underlying)
  • Disposition to Issuer

    Employee Stock Options

    2022-10-124,2540 total
    Exercise: $40.04Exp: 2027-02-18Common Stock (4,254 underlying)
  • Disposition to Issuer

    Employee Stock Options

    2022-10-12$1.94/sh7,196$13,9600 total
    Exercise: $36.35Exp: 2028-03-04Common Stock (7,196 underlying)
  • Disposition to Issuer

    Employee Stock Options

    2022-10-12$9.92/sh2,058$20,4150 total
    Exercise: $28.37Exp: 2027-04-24Common Stock (2,058 underlying)
  • Disposition to Issuer

    Common Stock

    2022-10-125,9470 total
  • Disposition to Issuer

    Restricted Stock Units

    2022-10-128,5910 total
    Common Stock (8,591 underlying)
  • Disposition to Issuer

    Employee Stock Options

    2022-10-122,1010 total
    Exercise: $45.96Exp: 2029-03-03Common Stock (2,101 underlying)
  • Disposition to Issuer

    Employee Stock Options

    2022-10-124,2010 total
    Exercise: $45.96Exp: 2029-03-03Common Stock (4,201 underlying)
Footnotes (4)
  • [F1]Represents shares of Terminix Global Holdings, Inc. ("Terminix") common stock disposed of in connection with the Agreement and Plan of Merger, dated as of December 13, 2021, as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of March 14, 2022 (the "Merger Agreement"), by and among Terminix, Rentokil Initial plc ("Rentokil Initial") and certain of Rentokil Initial's subsidiaries. In accordance with the Merger Agreement, at the First Effective Time (as defined in the Merger Agreement), each share of Terminix common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive at the prior election of the holder, either: (x) 1.4899 American depositary shares of Rentokil Initial ("Rentokil Initial ADSs"); or (y) $34.57 in cash and 0.1447 Rentokil Initial ADSs.
  • [F2]Each outstanding Terminix option then vested was converted into the right to receive an amount in cash of $38.29, less the applicable exercise price. Where the exercise price exceeded the cash consideration, the Terminix options were cancelled for no consideration.
  • [F3]Each outstanding Terminix option not vested was assumed by Rentokil Initial and converted into Rentokil Initial options pursuant to the terms of the Merger Agreement.
  • [F4]Each outstanding Terminix equity award that was not then vested was assumed by Rentokil Initial and (a) for Terminix time-vesting restricted stock units, each such award was converted into a number of time-vesting restricted stock units; and (b) otherwise will continue to vest and be settled on the same terms and conditions as applicable to the Terminix awards prior to the consummation of the transaction (except that, consistent with the Terminix equity plan, such unvested converted awards will fully vest upon a qualifying termination of employment occurring after the consummation of the transaction). The Terminix time-vesting restricted stock units were converted into Rentokil Initial restricted stock units pursuant to the terms of the Merger Agreement.

Issuer

TERMINIX GLOBAL HOLDINGS INC

CIK 0001428875

Entity typeother

Related Parties

1
  • filerCIK 0001854803

Filing Metadata

Form type
4
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 7:05 PM ET
Size
23.9 KB